Selective Deletion of Human Leukocyte Antigens Protects Stem Cell-Derived Islets from Immune Rejection

Scientists used genetic engineering to create human PSCs in which the majority of the polymorphic human leukocyte antigens, the main drivers of allogeneic rejection, were deleted.